Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, July 2001, p. 2064-2069, Vol. 45, No. 7
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.7.2064-2069.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Antimonial-Mediated DNA Fragmentation in
Leishmania infantum Amastigotes
Denis
Sereno,1
Philippe
Holzmuller,1
Isabelle
Mangot,1
Gérard
Cuny,3
Ali
Ouaissi,2 and
Jean-Loup
Lemesre1,*
Laboratoire de Biologie
Parasitaire,1 CJF-INSERM
N°96/04,2 and Laboratoire de
Parasitologie et Entomologie
Moléculaire,3 Centre IRD (Institut de
Recherche pour le Développement), 34032 Montpellier Cedex 1, France
Received 30 November 2000/Returned for modification 25 January
2001/Accepted 2 April 2001
 |
ABSTRACT |
The basic treatment of leishmaniasis consists in the administration
of pentavalent antimonials. The mechanisms that contribute to
pentavalent antimonial toxicity against the intracellular stage of the
parasite (i.e., amastigote) are still unknown. In this study, the
combined use of several techniques including DNA fragmentation assay
and in situ and cytofluorometry terminal
deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling
methods and YOPRO-1 staining allowed us to demonstrate that potassium
antimonyl tartrate, an Sb(III)-containing drug, was able to induce cell
death associated with DNA fragmentation in axenic amastigotes of
Leishmania infantum at low concentrations (10 µg/ml).
This observation was in close correlation with the toxicity of Sb(III)
species against axenic amastigotes (50% inhibitory concentration of
4.75 µg/ml). Despite some similarities to apoptosis, nuclease
activation was not a consequence of caspase-1, caspase-3, calpain,
cysteine protease, or proteasome activation. Altogether, our results
demonstrate that the antileishmanial toxicity of Sb(III) antimonials is
associated with parasite oligonucleosomal DNA fragmentation, indicative
of the occurrence of late events in the overall process of apoptosis.
The elucidation of the biochemical pathways leading to cell death could
allow the isolation of new therapeutic targets.
 |
INTRODUCTION |
Leishmaniasis is a significant cause
of morbidity and mortality in several countries. A vertebrate host is
infected with flagellated extracellular promastigote forms via the bite
of a sand fly. Promastigotes are rapidly transformed into
nonflagellated amastigotes dividing actively within the mononuclear
phagocytes of the vertebrate host. The basic treatment consists in the
administration of sodium stibogluconate (Pentostam), meglumine
(Glucantime), pentamidine, or amphotericin B. Treatment failure,
especially for kala-azar, mucosal leishmaniasis, and diffuse cutaneous
leishmaniasis is becoming a common problem in many areas where
leishmaniasis is endemic. Immunological, physiological, or
pharmacological deficiencies in the host are possible explanations for
variations in clinical response (29). But there is
evidence that inherent lack of susceptibility and (or) the development of resistance can also contribute to parasite unresponsiveness to drugs
(13, 18, 23, 28, 39, 40). The mode of action of
pentavalent antimonials remains poorly understood (3, 4, 5). An in vivo metabolic conversion of pentavalent antimonial [Sb(V)] into trivalent ones [Sb(III)] was suggested more than 50 years ago by Goodwin and Page (15, 16). This hypothesis was supported by the high toxicity of trivalent antimony against both
parasite stages of different Leishmania species (10,
14, 26, 31, 34). Recently, we and other investigators have shown that axenically grown amastigotes of Leishmania represent a
powerful model to investigate drug activity on the active and dividing population of the mammalian parasite stage (7, 34). We
have shown that potassium antimonyl tartrate [containing Sb(III)] was generally more toxic than pentavalent antimony [Sb(V)] for both parasite stages of different Leishmania species and
demonstrated that the extracellular amastigotes of Leishmania
infantum were the Leishmania species most susceptible
to Sb(III) (35). Moreover, in vitro-selected
Sb(III)-resistant axenic amastigotes expressed a strong
cross-resistance to meglumine when growing in THP-1 cells (37). A stage-specific susceptibility of amastigotes
towards antimonials has also been proposed. This hypothesis is based on the assumption that amastigotes of Leishmania donovani are
able to reduce pentavalent antimonial into a trivalent one (11,
12).
There are now increasing numbers of reports of single-celled organisms
that kill themselves by a mechanism whose activation is not obligatory
but can be used in threatening situations (i.e., apoptosis)
(2). Drugs, toxins, and physical injuries could also
provoke apoptosis in mammalian cells (1, 9, 41). Interestingly, arsenite-mediated apoptosis has been characterized and
extensively studied in mammalian cells (8, 20, 24, 43,
44). As antimonials share several chemical properties with
arsenicals, trivalent antimonial-mediated apoptosis has been studied
and reported in NB4 and NB4R4 cells (27). In order to more
precisely clarify the mode of action of antimonials against the
amastigote forms of L. infantum, we have investigated the type of cell death induced by antimonials.
In this study, we demonstrate that the cell death mediated by
antimonials presents some features previously shown to be induced by
heat shock in the promastigote forms of Leishmania
amazonensis (25), by antibiotic G418 in the
epimastigote forms of Trypanosoma cruzi (1),
and by reactive oxygen species in Trypanosoma brucei (30, 45). Trivalent antimonials (tartar emetic) species
were able to kill amastigotes with a cell death phenotype presenting some homologies with the programmed cell death observed in metazoans (i.e., DNA fragmentation). The term apoptosis, which was originally defined purely on morphological grounds, has been recently redefined as
"caspase-mediated cell death with associated apoptotic morphology" (32, 42). Our study suggests that nuclease activation does not depend on caspase-1, caspase-3, calpain, cystein protease, or
proteasome activation. These results suggest that the cell death
pathway involved in antimonial toxicity should be different from those
involved in metazoan apoptosis. The implication of these observations
on the antimonial mode of action is discussed.
 |
MATERIALS AND METHODS |
Materials.
Meglumine (Glucantime, batch no. 331-2, which
does not contain m-chlorocresol as preservative) was
supplied by Rhône Poulenc Specia. Z-DEVD-CMK, Z-VAD-FMK, calpain
I inhibitor, E-64
(2S,3S)-trans-epoxy-epoxysuccinyl-L-leucylamido-3-methylbutane ethyl ester, lactacystin, potassium antimonyl tartrate trihydrate, geneticin, and amphotericin B were supplied from Sigma.
Parasites and cultures.
A cloned line of L. infantum (MHOM/MA/67/ITMAP-263) was used in all experiments.
Axenically grown amastigote forms of L. infantum were
maintained at 37°C with 5% CO2 by weekly subpassages in
a cell-free medium called MAA/20 (medium for axenically grown
amastigotes) in 25-cm2 flasks as previously described
(25, 26, 43, 44). From a starting inoculum of 5 × 105 amastigote forms/ml, cell density of about 5 × 107 parasites/ml was obtained on day 7. MAA/20 consisted of
modified medium 199 (Gibco BRL) with Hanks' balanced salt solution
supplemented with 0.5% soy trypto-casein (Pasteur Diagnostics, Marne
la Coquette, France), 0.01 mM bathocuproine disulphonic acid, 3 mM
L-cysteine, 15 mM D-glucose, 5 mM
L-glutamine, 4 mM NaHCO3, 0.023 mM bovine hemin, and 25 mM HEPES to a final pH of 6.5 and supplemented by 20%
pretested fetal calf serum (21, 22, 33, 36).
Selection of antimonyl Sb(III)-resistant amastigote forms.
Cloned wild-type amastigote forms of L. infantum (designated
as LdiWT) were subjected to stepwise-increasing drug pressure until
cell lines resistant to 120 µg of potassium antimonyl tartrate trihydrate per ml were established. Fifty-percent-inhibitory
concentrations were determined using the micromethod previously
described (34, 35, 37). All amastigote populations
[wild-type and Sb(III)-resistant clones] were subjected to similar in
vitro culture subpassages.
In situ TUNEL assay.
DNA fragmentation was analyzed in situ
using a colorimetric detection system (Promega, Madison, Wis.). Slides
containing treated and untreated infected macrophages and axenic
amastigotes were fixed for 20 min with formaldehyde (4%; Sigma),
washed with phosphate-buffered saline (PBS) (0.01 M, pH 7.2), and
stored at
20°C until used. The terminal
deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling
(TUNEL) protocol involved a 10-min preincubation period with terminal
transferase (TdT) buffer. The reaction was carried out in a 50-µl
final volume with terminal transferase (0.5 µl) and biotinylated dUTP
(0.5 µl) in 1× TdT buffer containing CoCl2. After 60 min
of incubation at 37°C in humidified chambers, slides were washed with
0.01 M PBS, pH 7.2, and the reaction was stopped by incubation of the
slides in 2× SSC (1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate)
for 15 min. The endogenous peroxidase was blocked by incubation of the
slides in 0.3% hydrogen peroxide for 5 min. After being washed, the
slides were incubated for 30 min in a solution of
streptavidin-horseradish peroxidase (1/500). Then peroxidase activity
was revealed using the peroxidase substrate (hydrogen peroxide) and the
chromogen diaminobenzidine. After an extensive washing in PBS, the
preparations were analyzed using a microscope at a magnification of
×1,000. Apoptotic nuclei were visualized and appeared dark brown.
Flow cytofluorometry analysis using TUNEL assay.
DNA
fragmentation was analyzed by cytofluorometry using the apoptosis
detection system (Promega). Briefly, 3 × 106 to
5 × 106 axenic amastigotes were washed twice with PBS
(0.01 M) and fixed with methanol-free formaldehyde (1%) for 20 min at
4°C followed by 70% ethanol, which makes cells permeable in the
TUNEL procedure. The fixed cells were washed with TdT buffer and
incubated in the presence of terminal transferase (0.5 µl) and
biotinylated dUTP (0.5 µl) in TdT buffer containing
CoCl2. After 30 min of incubation at 37°C, the
biotin-labeled cells were stained with avidin-fluorescein isothiocyanate. The DNA was stained with 1 µg of propidium iodide per
ml before analysis on a FACScan flow cytometer (Becton Dickinson, Ivry, France).
Flow cytofluorometry analysis using YOPRO-1.
The percentage
of apoptotic cells was quantitated by flow cytofluorometry analysis
using the impermeant DNA intercalating YOPRO-1 (YP) as previously
described (19). Briefly, 106 L. infantum axenic amastigotes were incubated with 10 µM YP for 10 min. Cells were immediately analyzed on the FACScan flow cytometer (Becton Dickinson) using an argon-ion laser tuned to 488 nm. Green cell
fluorescence, gated on forward and side-light scatter, was collected
using a band-pass filter (525 ± 10 nm) and displayed using a
logarithmic amplification (FL-1).
DNA agarose gel electrophoresis.
Qualitative analysis of DNA
fragmentation was performed as previously described (1) by
agarose gel electrophoresis of DNA extracted from 5 × 108 amastigotes. Cell pellets were incubated in lysis
buffer (10 mM Tris, 10 mM EDTA, 0.5% Triton X-100, pH 7.4) for 30 min
at 4°C. The mixture was then submitted to proteolysis (proteinase K,
20-µg/ml final concentration; Boehringer Mannheim) for 2 h at
50°C, and lysates were centrifuged at 18,000 × g for
30 min at 4°C. DNA from supernatants, purified by the
phenol-chloroform extraction method, was precipitated in the presence
of 0.5 M NaCl (final concentration) and 1 volume of isopropanol. After
a washing by 70% ethanol, DNA was air dried and dissolved in 10 µl
of distilled water and 10 µg of DNA from Sb(III)-treated and
untreated parasites was electrophoresed in the presence of 1 µl of
migration buffer (40 mM Tris, 20 mM sodium acetate, 1 mM EDTA, pH 8.5 [Tris-borate-EDTA], 50% glycerol) on a 2% agarose gel in
Tris-borate-EDTA buffer for 2 h at 100 V. DNA was then visualized
under UV light after gel staining with ethidium bromide.
 |
RESULTS |
Antimonial-mediated DNA fragmentation on axenic amastigotes of
L. infantum.
When LdiWT axenic amastigotes were
treated with 10 µg of trivalent antimonials per ml for 24 h (50%
inhibitory concentration after 3 days, about 4.75 µg/ml), DNA
fragmentation could be detected via the evaluation of endonuclease
activity, by using the TUNEL method (Fig.
1C), compared to control untreated
parasites, for which DNA fragmentation was not detected (Fig. 1A).
Nuclei of Sb(III)-treated parasites were stained dark brown as observed with positive control (Fig. 1B). Geneticin was also able to promote DNA
fragmentation on axenic amastigotes of L. infantum at a
concentration of 1 mg/ml (Fig. 1E). By contrast, nuclei of the
chemoresistant mutants (LdiR120) treated with 50 µg of Sb(III)
antimonials per ml were not labeled by the TUNEL technique (Fig. 1F)
like the nuclei of wild-type parasites treated with 160 mg of meglumine Sb(V) (Fig. 1D). These results were confirmed using the flow cytometry TUNEL assay. First, geneticin at a concentration of 2 mg/ml induced apoptosis-like changes as shown by the increase in yellow-green fluorescence intensity gated on FL1 (Fig.
2B), unlike what is seen for the
untreated cells (Fig. 2A). The specificity of the reaction was
monitored by performing a negative control on the geneticin-treated
amastigotes (Fig. 2C). Wild-type amastigotes incubated in the presence
of 10 or 50 µg of Sb(III) per ml expressed a large increase in the
FL1 fluorescence (Fig. 2D and E) compared to the untreated control
(Fig. 2A). LdiR120 mutants treated with 50 µg of Sb(III) per ml
showed only a slight increase in FL1 fluorescence compared to untreated
parasites LdiR120 (Fig. 2G and H). These results strongly suggest that
trivalent antimonials were able to readily induce DNA fragmentation on
the clinically relevant stage of the parasite. To confirm this
observation, a YOPRO-1 staining method was used to monitor the
Sb(III)-mediated cell death. YOPRO-1 has been shown to permit the
cytofluorometric analysis of programmed cell death (apoptosis) in
mammalian cells (19). It has been used by Ameisen et al.
(1) for monitoring the complement-induced apoptosis-like
changes in T. cruzi epimastigotes. As shown in Fig. 3C and
D, cells submitted to geneticin-mediated
cell death were easily distinguished from living (Fig. 3A and B) or
necrotic (Fig. 3E and F) ones by using the combined analysis of their
different patterns of forward and side-light scatter properties and
YOPRO-1 staining. Susceptible wild-type amastigotes of L. infantum treated with 50 µg of Sb(III) per ml expressed the
cytofluorometry features of geneticin-treated cells. More than 60% of
the parasite population presents apoptotic-like features (Fig. 3G and
H). The apoptosis-like death which has been shown to occur in
Sb(III)-treated amastigotes using either the TUNEL technique or
YOPRO-1 staining was also detected by monitoring the genomic DNA
status of treated versus untreated parasites. As shown in Fig.
4 (lane 1), DNA fragmentation into
fragments of about 200 bp, close to the oligonucleosome-sized fragment
observed during apoptosis, was readily visible in the case of the
Sb(III)-treated amastigotes. No fragmentation was detected in the case
of the untreated LdiWT amastigotes (Fig. 4, lane 2).

View larger version (94K):
[in this window]
[in a new window]
|
FIG. 1.
In situ analysis of L. infantum axenic
amastigote DNA fragmentation (TUNEL). Shown are positive-control
untreated wild-type amastigotes (A), wild-type untreated parasites
whose DNA was digested by DNase I for 10 min (B), wild-type parasites
treated with 10 µg of potassium antimonyl tartrate [Sb(III)] per ml
for 24 h (C), with 160 µg of meglumine [Sb(V)] per ml for
24 h (D), or with 1 mg of geneticin per ml for 24 h (E), and
LdiR120 mutants treated with 50 µg of potassium antimonyl tartrate
[Sb(III)] per ml for 24 h (F). DNA fragmentation was determined
using the TUNEL method and analyzed under a microscope at a
magnification of ×1,600.
|
|

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 2.
Cytofluorometry (TUNEL) analysis of the
antimonial-induced DNA fragmentation in axenic amastigotes. Results are
shown for untreated wild-type parasite control (A) and wild-type
amastigotes incubated for 24 h with medium in the presence of 2 mg
of geneticin per ml (B), 2 mg of geneticin per ml without terminal
transferase enzyme (negative control) (C), 10 and 50 µg of potassium
antimonyl tartrate [Sb(III)] per ml (D and E, respectively), or 160 µg of meglumine [Sb(V)] per ml (F). Results for untreated LdiR120
amastigotes (G) and LdiR120 amastigotes incubated in medium containing
50 µg of potassium antimonyl tartrate per ml (H) are shown. After the
incubation period, parasites were processed by the TUNEL technique and
analyzed on a FACScan (Becton Dickinson). The increase in FL1
fluorescence intensity was monitored. The percentage of apoptotic cells
which corresponds to an increase of FL1 fluorescence (M2) is indicated
for each experimental condition.
|
|

View larger version (50K):
[in this window]
[in a new window]
|
FIG. 3.
Analysis of the antimonial-induced death of axenic
amastigotes using the cytofluorometry YOPRO-1 differential-staining
technique. Parasites were incubated in the absence (A and B) or
presence of 2 mg of geneticin per ml (C and D), for 10 min in the
presence of saponin (E and F), for 24 h in medium containing 50 µg of potassium antimonyl tartrate per ml (G and H) and in the
presence of 160 µg of meglumine [Sb(V)] for 24 h (I and J) or
for 5 days (K and L). The percentages of cells presenting
apoptosis-like changes and corresponding to both reduced forward
scatter and high fluorescence intensity (R2) are indicated in each
experimental condition. M1 (panels B, D, F, H, J, and L), peak of
fluorescence intensity.
|
|

View larger version (73K):
[in this window]
[in a new window]
|
FIG. 4.
Oligonucleosomal-DNA fragmentation analysis. Agarose gel
electrophoresis of DNA is shown. Lane 1, Sb(III)-treated LdiWT (50 µg/ml for 24 h); lane 2, untreated LdiWT amastigote parasites;
lane 3, molecular size markers.
|
|
The results presented so far demonstrate that cell death in amastigote
forms of
L. infantum could be associated with endonuclease
activity, which is responsible for the DNA fragmentation that
occurs as
a result of apoptosis. In mammalian cells, cysteine
proteases of the
caspase family, Ca
+-sensitive calpains, or proteasome can
initiate cell death. However,
we report that inhibitors of caspase-3
(inhibitory peptide Z-DEVD-CMK,
5 µM) and caspase-1 (inhibitory
peptide Z-VAD-FMK, 5 µM), calpain
(calpain I inhibitor, 20 µM),
cysteine proteases [E-64,
(2
S,3
S)-trans-epoxy-epoxysuccinyl-
L-leucylamido-3-methylbutane
ethyl ester, 20 µM] or proteasome (lactacystin, 10 µM) were
without
effect on cell death brought about by trivalent antimonial on
axenic amastigotes of
L. infantum (data not
shown).
 |
DISCUSSION |
Apoptosis-like changes have been reported for T. cruzi
in response to conditioned medium or the antibiotic G418
(1). A shift in the distribution of elongation factor
1-alpha (EF-1
) to a nuclear localization was reported as one of the
changes accompanying cell death (6). In L. amazonensis, apoptosis-like changes were reported in response to
heat shock (25). In this study, we demonstrate that
antimonials in clinical use were able to induce cell death with
features of apoptosis (i.e., DNA fragmentation) on the clinically relevant stage of L. infantum.
The combined use of several techniques including YOPRO-1 staining,
DNA fragmentation assay and in situ and cytofluorometry TUNEL methods
demonstrated that the toxicity of Sb(III) species against axenic
amastigotes is associated with oligonucleosomal DNA fragmentation,
indicative of the occurrence of late events in the overall process of
apoptosis. The death, mediated by Sb(III) species on axenic
amastigotes, is massive even after a short incubation period (1 day)
and at low concentration (10 µg/ml). These observations were in
agreement with previous reports showing a relatively high efficacy of
trivalent antimonials against axenic amastigotes of various
Leishmania species (12, 13, 37, 38). We show
that meglumine has no effect either on the viability (37)
or on the DNA status of axenic amastigotes, suggesting that macrophages probably play an important role in pentavalent antimonial toxicity against intracellular amastigotes.
The biochemical pathways that mediate or regulate the endonuclease
activity in trypanosomatids are still unknown. In multicellular organisms, protease activation is an important component of the cell
death process (17). Recent studies have demonstrated that in T. brucei brucei reactive oxygen species initiate a
Ca+-dependent sequence of events associated with
endonuclease activity which culminates in cell death (30).
In order to clarify more precisely the implication of protease in the
DNA fragmentation induced by antimonials, we used several inhibitors.
Although inhibitors of some caspases were not tried, the inhibitors
used are known at least to block the caspases directly and indirectly
responsible for the activation of endonuclease activity (caspase-1 and
caspase-3). The lack of involvement of calpains, proteasome, and
cysteine proteases suggests that some specific proteins, distinct from those in metazoans, are involved in the cell death promoted by antimonials as has been suggested for T. brucei brucei
(30). Finally, as antimonials have been in clinical use
since 1940 and continue to be the mainstay of antileishmanial therapy,
it could be reasonably assumed that a better understanding of the
mechanisms that regulate the cell death in chemoresistant mutants may
help us to design new therapeutic strategies against
Leishmania parasites.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Laboratoire de
Biologie Parasitaire, IRD, 911 Av. Agropolis, BP 5045, 34032 Montpellier Cedex 1, France. Phone: (33) 04 67 41 62 20. Fax: (33) 04 67 54 78 00. E-mail: Lemesre{at}mpl.ird.fr.
 |
REFERENCES |
| 1.
|
Ameisen, J. C.,
T. Idziorek,
O. Billaut-Mullot,
J. P. Tissier,
A. Potentier, and A. Ouaissi.
1995.
Apoptosis in a unicellular eukaryote (Trypanosoma cruzi): implication for the evolutionary origin and role of programmed cell death in the control of cell proliferation, differentiation and survival.
Cell Death Differ.
2:285-300.
|
| 2.
|
Ameisen, J. C.
1996.
The origin of programmed cell death.
Science
272:1278-1279[Medline].
|
| 3.
|
Berman, J. D.
1988.
Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy and future strategies.
Rev. Infect. Dis.
10:560-586[Medline].
|
| 4.
|
Berman, J. D.,
D. Waddell, and B. D. Hanson.
1985.
Biochemical mechanisms of the antileishmanial activity of sodium stibogluconate.
Antimicrob. Agents Chemother.
27:916-920[Abstract/Free Full Text].
|
| 5.
|
Berman, J. D.,
J. V. Gallalee, and J. M. Best.
1987.
Sodium stibogluconate (pentostam) inhibition of glucose catabolism via the glycolytic pathway, and fatty acid beta oxidation in Leishmania mexicana amastigotes.
Biochem. Pharmacol.
36:197-201[CrossRef][Medline].
|
| 6.
|
Billaut-Mulot, O.,
R. Fernandez-Gomez,
M. Loyens, and A. Ouaissi.
1996.
Trypanosoma cruzi elongation factor 1-alpha: nuclear localization in parasites undergoing apoptosis.
Gene
174:19-26[CrossRef][Medline].
|
| 7.
|
Callahan, H. L.,
A. C. Portal,
R. Devereaux, and M. Grögl.
1997.
An axenic amastigote system for drug screening.
Antimicrob. Agents Chemother.
41:818-822[Abstract].
|
| 8.
|
Chen, Y. C.,
S. Y. Lin-Shiau, and J. K. Lin.
1998.
Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis.
J. Cell. Physiol.
177:323-333.
|
| 9.
|
Cohen, J. J.
1993.
Apoptosis.
Immunol. Today
14:126-130[Medline].
|
| 10.
|
Coombs, G. H.,
J. A. Craft, and D. T. Hart.
1982.
A comparative study of Leishmania mexicana amastigotes and promastigotes. Enzyme activities and subcellular locations.
Mol. Biochem. Parasitol.
5:199-211[CrossRef][Medline].
|
| 11.
|
Ephros, M.,
A. Bitnun,
P. Shaked,
E. Waldman, and D. Zilberstein.
1999.
Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes.
Antimicrob. Agents Chemother.
43:278-282[Abstract/Free Full Text].
|
| 12.
|
Ephros, M.,
E. Waldman, and D. Zilberstein.
1997.
Pentostam induces resistance to antimony and the preservative chlorocresol in Leishmania donovani promastigotes and axenically grown amastigotes.
Antimicrob. Agents Chemother.
41:1064-1068[Abstract].
|
| 13.
|
Faraut-Gambarelli, F.,
R. Piarroux,
M. Deniau,
B. Giusano,
P. Marty,
G. Michel,
B. Faugère, and H. Dumon.
1997.
In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis.
Antimicrob. Agents Chemother.
41:827-830[Abstract].
|
| 14.
|
Gebre-Hiwot, A.,
G. Tadesse,
S. L. Croft, and D. Frommel.
1992.
An in vitro model for screening antileishmanial drugs: the human leukemia monocyte cell line, THP-1.
Acta Trop.
51:237-245[CrossRef][Medline].
|
| 15.
|
Goodwin, L. G., and J. E. Page.
1943.
A study of the excretion of organic antimonials using a polarographic procedure.
Biochem. J.
22:236-240.
|
| 16.
|
Goodwin, L. C.
1995.
Pentostam (sodium stibogluconate); a 50-year personal reminiscence.
Trans. R. Soc. Trop. Med. Hyg.
89:339-341[CrossRef][Medline].
|
| 17.
|
Green, D., and G. Kroemer.
1998.
The central executioners of apoptosis: caspases or mitochondria?
Trends Cell Biol.
8:267-271[CrossRef][Medline].
|
| 18.
|
Grögl, M.,
T. N. Thomason, and E. Franke.
1992.
Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease.
Am. J. Trop. Med. Hyg.
47:117-126.
|
| 19.
|
Idzioreck, T.,
J. Estaquier,
F. De Bels, and J. C. Ameisen.
1995.
YOPRO-1 permits cytofluorometric analysis of programmed cell death (apoptosis) without interfering with cell viability.
J. Immunol. Methods
185:249-258[CrossRef][Medline].
|
| 20.
|
Larochette, N.,
D. Decaudin,
E. Jacobot,
C. Brenner,
I. Marzo,
S. A. Susin,
N. Zamzami,
Z. Reed, and G. Kroemer.
1999.
Arsenite induces apoptosis via direct effect on the mitochondrial permeability transition pore.
Exp. Cell Res.
249:413-421[CrossRef][Medline].
|
| 21.
| Lemesre, J. L. May 1994. Methods for the
culture in vitro of different stages of tissue parasites. International
publication no. WO 94/26899.
|
| 22.
|
Lemesre, J. L.,
D. Sereno,
S. Daulouède,
B. Veyret,
N. Brajon, and P. Vincendeau.
1997.
Leishmania spp: nitric oxide-mediated metabolic inhibition of promastigote and axenically-grown amastigote forms.
Exp. Parasitol.
86:58-68[CrossRef][Medline].
|
| 23.
|
Lira, R.,
S. Sundar,
A. Makharia,
R. Kenney,
A. Gam,
E. Saraiva, and D. Sacks.
1999.
Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani.
J. Infect. Dis.
180:564-567[CrossRef][Medline].
|
| 24.
|
Ma, D. C.,
Y. H. Sun,
K. Z. Chang,
X. F. Ma,
S. L. Huang,
Y. H. Bai,
J. Kang,
Y. G. Liu, and J. J. Chu.
1998.
Selective induction of apoptosis of NB4 cells from G2+M phase by sodium arsenite at lower doses.
Eur. J. Haematol.
61:27-35[Medline].
|
| 25.
|
Moreira, M. E.,
H. A. Del Portillo,
R. V. Milder,
J. M. Balanco, and M. A. Barcinski.
1996.
Heat shock induction of apoptosis in promastigotes of the unicellular organism Leishmania (Leishmania) amazonensis.
J. Cell. Physiol.
167:305-313[CrossRef][Medline].
|
| 26.
|
Mottram, J. C., and G. H. Coombs.
1985.
Leishmania mexicana: enzyme activities of amastigotes and promastigotes and their inhibition by antimonials and arsenicals.
Exp. Parasitol.
59:151-160[CrossRef][Medline].
|
| 27.
|
Müller, S.,
W. H. Miller, and A. Dejean.
1998.
Trivalent antimonials induce degradation of the PML-RAR oncoprotein and reorganization of the promyelocytic leukemia nuclear bodies in acute leukemia NB4 cells.
Blood
92:4308-4316[Abstract/Free Full Text].
|
| 28.
|
Ouellette, M., and B. Papadopoulou.
1993.
Mechanisms of drug resistance in Leishmania.
Parasitol. Today
9:150-153[CrossRef][Medline].
|
| 29.
|
Peters, B. S.,
D. Fish,
R. Golden,
D. A. Evans,
A. D. M. Bryceson, and A. J. Pinching.
1990.
Visceral leishmaniasis in HIV infection and AIDS: clinical features and response to therapy.
Q. J. Med.
77:1101-1111[Abstract/Free Full Text].
|
| 30.
|
Ridgley, E. L.,
Z. H. Xiong, and L. Ruben.
1999.
Reactive oxygen species activate a Ca2+-dependent cell death pathway in the unicellular organism Trypanosoma brucei brucei.
Biochem. J.
340:33-40.
|
| 31.
|
Roberts, W. L.,
J. D. Berman, and P. M. Rainey.
1995.
In vitro antileishmanial properties of tri- and pentavalent antimonial preparations.
Antimicrob. Agents Chemother.
39:1234-1239[Abstract].
|
| 32.
|
Samali, A.,
B. Zhivotovsky,
D. Jones,
S. Nagata, and S. Orrenius.
1999.
Apoptosis: cell death defined by caspase activation.
Cell Death Differ.
6:495-496[CrossRef][Medline].
|
| 33.
|
Sereno, D., and J. L. Lemesre.
1997.
In vitro life cycle of pentamidine-resistant amastigotes: stability of the chemoresistant phenotypes is dependent on the level of resistance induced.
Antimicrob. Agents Chemother.
41:1898-1903[Abstract].
|
| 34.
|
Sereno, D., and J. L. Lemesre.
1997.
Axenically cultured amastigote forms as an in vitro model for investigation of antileishmanial agents.
Antimicrob. Agents Chemother.
41:972-976[Abstract].
|
| 35.
|
Sereno, D., and J. L. Lemesre.
1997.
Use of an enzymatic in vitro micromethod to quantify amastigote stage of axenically grown amastigote forms of Leishmania amazonensis.
Parasitol. Res.
83:401-403[CrossRef][Medline].
|
| 36.
|
Sereno, D.,
P. Michon,
N. Brajon, and J. L. Lemesre.
1997.
Phenotypic characterization of Leishmania mexicana pentamidine-resistant promastigotes: modulation of the resistance during developmental life cycle.
C. R. Acad. Sci.
320:981-987.
|
| 37.
|
Sereno, D.,
M. Cavaleyra,
K. Zemzoumi,
S. Maquaire,
A. Ouaissi, and J. L. Lemesre.
1998.
Axenically-grown amastigotes of Leishmania infantum used as an in vitro model to investigate the pentavalent antimony mode of action.
Antimicrob. Agents Chemother.
42:3097-3102[Abstract/Free Full Text].
|
| 38.
|
Sereno, D.,
G. Roy,
J. L. Lemesre,
B. Papadopoulou, and M. Ouellette.
2001.
DNA transformation of Leishmania infantum axenic amastigote and their use in drug screening.
Antimicrob. Agents Chemother.
45:1168-1173[Abstract/Free Full Text].
|
| 39.
|
Ullman, B.
1995.
Multidrug resistance and P-glycoproteins in parasitic protozoa.
J. Bioenerg. Biomembr.
27:77-84[CrossRef][Medline].
|
| 40.
|
Ullman, B.,
E. Carrero-Valenzuella, and T. Coons.
1989.
Leishmania donovani: isolation and characterization of sodium stibogluconate (Pentostam)-resistant cell lines.
Exp. Parasitol.
69:157-163[CrossRef][Medline].
|
| 41.
|
Vaux, D. L., and A. Strasser.
1996.
The molecular biology of apoptosis.
Proc. Natl. Acad. Sci. USA
93:2239-2244[Abstract/Free Full Text].
|
| 42.
|
Vaux, D. L.
1999.
Caspases and apoptosis-biology and terminology.
Cell Death Differ.
6:493-494[CrossRef][Medline].
|
| 43.
|
Wang, T. S.,
C. F. Kuo,
K. Y. Jan, and H. Huang.
1996.
Arsenite induces apoptosis in chinese hamster ovary cells by generation of reactive oxygen species.
J. Cell. Physiol.
169:256-268[CrossRef][Medline].
|
| 44.
|
Watson, R. W.,
H. P. Redmond,
J. H. Wang, and D. Bouchler-Hayes.
1996.
Mechanisms involved in sodium arsenite-induced apoptosis of human neutrophils.
J. Leukoc. Biol.
60:625-632[Abstract].
|
| 45.
|
Welburn, S. C.,
M. A. Barcinski, and G. T. Williams.
1997.
Programmed cell death in trypanosomatids.
Parasitol. Today
13:22-26[CrossRef][Medline].
|
Antimicrobial Agents and Chemotherapy, July 2001, p. 2064-2069, Vol. 45, No. 7
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.7.2064-2069.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Singh, N., Gupta, R., Jaiswal, A. K., Sundar, S., Dube, A.
(2009). Transgenic Leishmania donovani clinical isolates expressing green fluorescent protein constitutively for rapid and reliable ex vivo drug screening. J Antimicrob Chemother
64: 370-374
[Abstract]
[Full Text]
-
Kumar, D., Kulshrestha, A., Singh, R., Salotra, P.
(2009). In Vitro Susceptibility of Field Isolates of Leishmania donovani to Miltefosine and Amphotericin B: Correlation with Sodium Antimony Gluconate Susceptibility and Implications for Treatment in Areas of Endemicity. Antimicrob. Agents Chemother.
53: 835-838
[Abstract]
[Full Text]
-
Alzate, J. F., Arias, A., Mollinedo, F., Rico, E., de la Iglesia-Vicente, J., Jimenez-Ruiz, A.
(2008). Edelfosine Induces an Apoptotic Process in Leishmania infantum That Is Regulated by the Ectopic Expression of Bcl-XL and Hrk. Antimicrob. Agents Chemother.
52: 3779-3782
[Abstract]
[Full Text]
-
Luque-Ortega, J. R., Rivas, L.
(2007). Miltefosine (Hexadecylphosphocholine) Inhibits Cytochrome c Oxidase in Leishmania donovani Promastigotes. Antimicrob. Agents Chemother.
51: 1327-1332
[Abstract]
[Full Text]
-
Ashutosh, , Sundar, S., Goyal, N.
(2007). Molecular mechanisms of antimony resistance in Leishmania. J Med Microbiol
56: 143-153
[Abstract]
[Full Text]
-
Vergnes, B., Gourbal, B., Girard, I., Sundar, S., Drummelsmith, J., Ouellette, M.
(2007). A Proteomics Screen Implicates HSP83 and a Small Kinetoplastid Calpain-related Protein in Drug Resistance in Leishmania donovani Clinical Field Isolates by Modulating Drug-induced Programmed Cell Death. Mol. Cell. Proteomics
6: 88-101
[Abstract]
[Full Text]
-
Croft, S. L., Sundar, S., Fairlamb, A. H.
(2006). Drug Resistance in Leishmaniasis. Clin. Microbiol. Rev.
19: 111-126
[Abstract]
[Full Text]
-
Holzmuller, P., Sereno, D., Lemesre, J.-L.
(2005). Lower Nitric Oxide Susceptibility of Trivalent Antimony-Resistant Amastigotes of Leishmania infantum. Antimicrob. Agents Chemother.
49: 4406-4409
[Abstract]
[Full Text]
-
Sereno, D., Alegre, A. M., Silvestre, R., Vergnes, B., Ouaissi, A.
(2005). In Vitro Antileishmanial Activity of Nicotinamide. Antimicrob. Agents Chemother.
49: 808-812
[Abstract]
[Full Text]
-
Wyllie, S., Cunningham, M. L., Fairlamb, A. H.
(2004). Dual Action of Antimonial Drugs on Thiol Redox Metabolism in the Human Pathogen Leishmania donovani. J. Biol. Chem.
279: 39925-39932
[Abstract]
[Full Text]
-
Zhou, Y., Messier, N., Ouellette, M., Rosen, B. P., Mukhopadhyay, R.
(2004). Leishmania major LmACR2 Is a Pentavalent Antimony Reductase That Confers Sensitivity to the Drug Pentostam. J. Biol. Chem.
279: 37445-37451
[Abstract]
[Full Text]
-
Verma, N. K., Dey, C. S.
(2004). Possible Mechanism of Miltefosine-Mediated Death of Leishmania donovani. Antimicrob. Agents Chemother.
48: 3010-3015
[Abstract]
[Full Text]
-
Mehta, A., Shaha, C.
(2004). Apoptotic Death in Leishmania donovani Promastigotes in Response to Respiratory Chain Inhibition: COMPLEX II INHIBITION RESULTS IN INCREASED PENTAMIDINE CYTOTOXICITY. J. Biol. Chem.
279: 11798-11813
[Abstract]
[Full Text]
-
Paris, C., Loiseau, P. M., Bories, C., Breard, J.
(2004). Miltefosine Induces Apoptosis-Like Death in Leishmania donovani Promastigotes. Antimicrob. Agents Chemother.
48: 852-859
[Abstract]
[Full Text]
-
Holzmuller, P., Sereno, D., Cavaleyra, M., Mangot, I., Daulouede, S., Vincendeau, P., Lemesre, J.-L.
(2002). Nitric Oxide-Mediated Proteasome-Dependent Oligonucleosomal DNA Fragmentation in Leishmania amazonensis Amastigotes. Infect. Immun.
70: 3727-3735
[Abstract]
[Full Text]